Sevabertinib in Advanced HER2-Mutant Non–Small-Cell Lung Cancer

Journal:
The New England Journal of Medicine
Published:
Affiliations:
33
Authors:
29
Institutions Authors Share
Bayer Consumer Care AG, Switzerland
2.000000
0.07
Bayer HealthCare, United States of America (USA)
2.000000
0.07
Netherlands Cancer Institute (NKI), Netherlands
1.000000
0.03
Wuhan Union Hospital, HUST, China
1.000000
0.03
The University of Texas MD Anderson Cancer Center, United States of America (USA)
1.000000
0.03
Curie Institute, France
1.000000
0.03
Seoul National University Hospital (SNUH), South Korea
1.000000
0.03
National Cancer Center Hospital, Japan
1.000000
0.03
The Chinese University of Hong Kong (CUHK), China
1.000000
0.03
San Luigi University Hospital, Italy
1.000000
0.03
Bayer S.p.A., Italy
1.000000
0.03
Dana-Farber Cancer Institute (DFCI), United States of America (USA)
1.000000
0.03
Sir Run Run Shaw Hospital (SRRSH), Zhejiang University School of Medicine, China
1.000000
0.03
Agostino Gemelli University Polyclinic, Italy
1.000000
0.03
Drum Tower Hospital, China
1.000000
0.03
Bayer, Germany
1.000000
0.03
Taichung Veterans General Hospital, Taiwan
1.000000
0.03
Bayer Plc, United Kingdom (UK)
1.000000
0.03
National Cancer Center Hospital East, Japan
1.000000
0.03
IRCCS National Cancer Institute (INT) Milan, Italy
1.000000
0.03
Shanghai Chest Hospital, SJTU, China
1.000000
0.03
Beijing Cancer Hospital / School of Oncology, PKUHSC, China
1.000000
0.03
National University Cancer Institute (NCIS), Singapore
0.500000
0.02
Yonsei Cancer Hospital, South Korea
0.500000
0.02
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), China
0.500000
0.02
National University of Singapore (NUS), Singapore
0.500000
0.02
Beijing Hospital, China
0.500000
0.02
Duke-NUS Medical School, Singapore
0.500000
0.02
National Cancer Centre Singapore (NCCS), Singapore
0.500000
0.02
Hunan Cancer Hospital, China
0.500000
0.02
Central South University (CSU), China
0.500000
0.02
Yonsei University, South Korea
0.500000
0.02